They sit at the edge of this list because the GLP-1 is only one half of the product
Summary Keywords GLP 1, nausea & vomiting, obesity, semaglutide, side effect, tirzepatide Citation Alhazmi A and le Roux CW (2026) Do no harm: managing nausea and vomiting in GLP-1 based obesity therapies
The active ingredient in the incretin mimetic is dulaglutide, which shares 90% of the amino acid sequence with naturally occurring GLP-1
Moreover, ACTL6A overexpression relieved the inhibited GC cell proliferation caused by ACTL6A expression knockdown (Supplementary Fig 1c, d)
(2025) describe oral involvement as part of partial unilateral lentiginosis - pigmented lesions that, when seen alongside skin and ocular findings, form a recognizable multi-system pattern